The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
Additionally, Spravato introduces a groundbreaking option to treat depression on an as-needed basis, rather than daily, accommodating diverse patient schedules and symptom patterns. Clinicians ...
Johnson & Johnson has priced its new Spravato nasal spray ... “Treatment-resistant forms of major depression are common and have large negative effects on patient quality of life, so new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback